OpenVSafe by OpenVAERS
Search V-safe

8DT-21352-66579

2 vaccinations 4 coded responses 23 check-ins 4 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
532 / WI
Registered
2021-03-27
Relationship
Self
Race
Multiracial
Ethnicity
Hispanic or Latino
Registered dependents
8FD-28820-66939 Child or adolescent in my care · Male · 2022-01-13

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2370584 (opens in a new window) high 9 / 11 2 7 of 34 VAERS symptoms same dose (2) WI matches 2021-04-22 / 2021-04-23 / 2022-07-15
received the same day as the last call
case 1113030

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-03-26
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-27
    Registered in v-safe
  3. 2021-03-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  4. 2021-03-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness, Nausea
    Adult check-in
  5. 2021-03-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Itching · None
    Adult check-in
  6. 2021-03-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-02
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-09
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-04-16
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-04-22
    Dose 2 — Pfizer-BioNTech
  12. 2021-04-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Feeling abnormal, Feeling hot, Paraesthesia — Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Brain fog, Tingling and extra warmth on left side of faces
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-04-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  14. 2021-04-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  15. 2021-04-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  16. 2021-04-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  17. 2021-04-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-04-29
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-05-06
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-13
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-20
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-27
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-06-03
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-07-22
    Survey response — 3 months, dose 2
    MedDRA: Breast inflammation, Emergency care, Heavy menstrual bleeding — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Prolonged and heavier menstruation along with breast inflammation. The first period was a couple days longer and slightly heavier than usual. Subsequent periods were even heavier. Latest period was 35 days long and so heavy, that I went to ER.
    MedDRA releases: 2024-11 · check-in free text available
  25. 2021-10-21
    Survey response — 6 months, dose 2
    MedDRA: Heavy menstrual bleeding, Menstrual disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    Free text: Continued Menstrual cycle changes. Heavier period and lasting longer than 1 month.
    MedDRA releases: 2024-11 · check-in free text available
  26. 2021-10-21
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
  27. 2022-04-22
    Survey response — 12 months, dose 2
    MedDRA: Costochondritis, Gastrointestinal disorder, Hypertension, Insomnia, Palpitations, Panic attack, Paraesthesia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Heart Palpitations, body buzzing, high blood pressure, pins and needle feeling in extremities, insomnia, panic attacks, gastrointestinal issues, costochondritis
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-07-15
    Call successful
    Completed over the phone

Vaccinations

DoseDateManufacturerCo-administered
12021-03-26Pfizer-BioNTech
22021-04-22Pfizer-BioNTech

Call center

1 call center case

1 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-23

Systemic reaction (other): Brain fog, Tingling and extra warmth on left side of faces

Release 9 — 3 months, dose 2

2021-07-22

Symptoms: Prolonged and heavier menstruation along with breast inflammation. The first period was a couple days longer and slightly heavier than usual. Subsequent periods were even heavier. Latest period was 35 days long and so heavy, that I went to ER.

Release 10 — 6 months, dose 2

2021-10-21

Symptoms: Continued Menstrual cycle changes. Heavier period and lasting longer than 1 month.

Release 11 — 12 months, dose 2

2022-04-22

Symptoms: Heart Palpitations, body buzzing, high blood pressure, pins and needle feeling in extremities, insomnia, panic attacks, gastrointestinal issues, costochondritis

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBreast inflammation · · ✓
SDCostochondritis · · ✓
SDEmergency care · · ✓
SDGastrointestinal disorder · · ✓
SDHeavy menstrual bleeding · · ✓
SDHypertension · · ✓
SDInsomnia · · ✓
SDMenstrual disorder · · ✓
SDPalpitations · · ✓
SDPanic attack · · ✓
SDParaesthesia · · ✓
SROFeeling abnormal ✓ ✓ ✓
SROFeeling hot ✓ ✓ ✓
SROParaesthesia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release